Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis

NCT05407246 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Active Ankylosing Spondylitis

Interventions

DRUG: Hemay005

Sponsor

Tianjin Hemay Pharmaceutical Co., Ltd